Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |